Overview
Soranib 200 mg Tablets contain Sorafenib, a multikinase inhibitor used in the treatment of specific cancers. It targets multiple enzymes involved in tumor cell proliferation and angiogenesis. Soranib is commonly prescribed for advanced renal cell carcinoma (RCC), unresectable hepatocellular carcinoma (HCC), and radioactive iodine-resistant differentiated thyroid carcinoma.





